Diagnostic and therapy of the complex regional pain syndrome
Our scientific studies of biological samples derived from CRPS patients demonstrated for the first time that the onset of CRPS is caused by autoantibodies against specific receptors, which activate these receptors and elicit, in the context of an autoimmune disease, neuronal inflammatory reactions. <br>
Specific ligands a patent is applied for are now provided. The ligands interact with these autoantibodies in the blood, thereby neutralizing them considerably. Bound for example to column material, the specific ligands can be employed for the therapy as well as the diagnosis of the complex regional pain syndrome, and even be used for prophylaxis.<br> As standard technology for diagnosis, in particular immunofluorescence has proven to be of value. In general, also other applications are possible.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Insect research is revolutionized by technology
New technologies can revolutionise insect research and environmental monitoring. By using DNA, images, sounds and flight patterns analysed by AI, it’s possible to gain new insights into the world of…
Expanding a lymph node, boosting a vaccine
A biomaterial vaccine enhances and sustains lymph node expansion following vaccination, boosting anti-tumor immunity in an animal model. Each one of us has around 600 lymph nodes (LNs) – small,…
AI to Make Crop Production More Sustainable
Drones monitoring fields for weeds and robots targeting and treating crop diseases may sound like science fiction but is actually happening already, at least on some experimental farms. Researchers from…
